Why the study?
Does controlled-release metoprolol improve survival and reduce hospitalizations in patients with symptomatic heart failure?
Population
Patients with symptomatic heart failure
Authors
Loading...
Supports metoprolol CR/XL initiation in symptomatic HF; confirms survival and hospitalization benefits in RCTs.
Does controlled-release metoprolol improve survival and reduce hospitalizations in patients with symptomatic heart failure?
Controlled-release metoprolol provides significant clinical benefits, including improved survival and reduced hospitalizations, in patients with symptomatic heart failure.
Hjalmarson et al. (2000) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: